Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 28, 2015 11:38 PM ET

Healthcare Providers and Services

Company Overview of Cancer Treatment Centers of America, Inc.

Company Overview

Cancer Treatment Centers of America, Inc. owns and operates cancer care hospitals. It offers medical oncology, surgical oncology, radiation oncology, hematologic oncology, and neurosurgery services; nutrition therapy, pain management, naturopathic medicine, mind-body medicine, oncology rehabilitation, and spiritual support; care management, patient relations, culinary services, outpatient accommodations, transportation, and activities and classes services; acupuncture, chiropractic care, survivorship support, patient education, pharmacy, and HCAHPS comparison services; and interventional pulmonology, gastroenterology, and interventional radiology services. Cancer Treatment Centers of America...

1336 Basswood Road

Schaumburg, IL 60173

United States

Founded in 1988





Key Executives for Cancer Treatment Centers of America, Inc.

Chief Executive Officer and President
Age: 54
Founder and Chairman of the Board
Chief Medical Information Officer, Senior Vice President of Information Services and Naturopathic Physician
Chief Operating Officer
Chief Executive Officer of Eastern Regional Medical Center and President of Eastern Regional Medical Center
Compensation as of Fiscal Year 2014.

Cancer Treatment Centers of America, Inc. Key Developments

Cancer Treatment Centers of America Launches Clinical Trial Combining Chemotherapy and Immunotherapy

Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) in Goodyear, Arizona is now accepting patients into a clinical trial that combines more traditional chemotherapy drugs (gemcitabine, docetaxel, nab-paclitaxel, vinorelbine, irinotecan, and/or liposomal doxorubicin) with immunotherapy (pembrolizumab), activating the body’s own immune system to improve upon results that may be achieved from chemotherapy alone. Uniquely, the PembroPlus Phase Ib and Phase II study will target patients with advanced metastatic sarcoma, small cell lung cancer, and pancreatic adenocarcinoma. There are anticipated to be up to 140 patients enrolled on this multi-arm study. Recent data reported in the New England Journal of Medicine1 and Lancet2 demonstrates promising results with antibody-based immunostimulatory therapy in treating melanoma, renal cell carcinoma, and non-small cell lung cancer. Data has also shown synergetic effects of utilizing cytotoxic chemotherapy in combination with immunostimulatory therapy. PembroPlus will build upon this data, extending treatment options to additional cancer types.

Cancer Treatment Centers of America Names Nancy Hesse as its Chief Nursing Officer

Cancer Treatment Centers of America has named Nancy Hesse, MSN, RN, as its Chief Nursing Officer. Hesse previously held the position of SVP, Patient of Care Services at CTCA - Eastern Regional Medical Center and will continue in that role while assuming her new position. In this position, Hesse will be responsible for leading the development and execution of system-wide programs and best practices for safety outcomes and clinical quality. Utilizing her leadership skills, Hesse will be the voice of nursing for CTCA to ensure that the nursing staff is heard and accounted for in organizational decisions. Hesse joined CTCA in January 2014 after serving as Chief Nursing Officer at Abington Health, Lansdale Hospital.

Maurie Markman Joins as President of Cancer Treatment Centers of America's Medicine & Science Unit

Cancer Treatment Centers of America announced the appointment of Maurie Markman, MD, as President of the company's Medicine & Science unit, in which capacity he will be responsible for advancing the organization's overall commitment to clinical excellence, innovation, safety, and patient satisfaction. Dr. Markman served most recently as Senior Vice President of Clinical Affairs & National Director of Medical Oncology at CTCA. In his new role, Dr. Markman will assume oversight of the CTCA national clinical team, with a focus on the application of all clinical and translational research to patient care. An expert in research on gynecologic malignancies, new drug development, and novel management strategies, Dr. Markman served in a variety of clinical leadership and academic positions at some of the country's leading cancer institutions prior to joining CTCA in 2010, including The Cleveland Clinic, the University of Texas - MD Anderson Cancer Center, The Ohio State University, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, and the University of California San Diego School of Medicine.

Similar Private Companies By Industry

Company Name Region
Lamplight Inn of Dayton United States
Sarasota-Manatee Jewish Housing Council, Inc. United States
Bedford Memorial Hospital United States
Kansas Heart Hospital, L.L.C United States
Miraca USA, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cancer Treatment Centers of America, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at